رجوع
نطاق اليوم
KWD 4.14
KWD 4.50
نطاق 52 أسبوعًا
KWD 2.28
KWD 4.59
حجم التداول
600
متوسط 50 يوم / 200 يوم
KWD 4.44
/
KWD 3.49
الإغلاق السابق
KWD 4.44
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.4 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -1251.1 | 3.9 |
| Rev Growth 5Y % | 150.8 | 10.0 |
| D/E | — | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
-KWD 0.109
-KWD 0.109 – -KWD 0.109
|
260 M | 4 |
| FY2028 |
-KWD 0.551
-KWD 0.551 – -KWD 0.551
|
96 M | 3 |
| FY2027 |
-KWD 0.674
-KWD 0.674 – -KWD 0.674
|
25 M | 2 |
النقاط الرئيسية
Revenue grew 150.82% annually over 5 years — strong growth
Negative free cash flow of -86.26M
Revenue growth is decelerating — 1Y growth trails 5Y average by 166.57%
Capital efficient — spends only 2.26% of revenue on capex
النمو
Revenue Growth (5Y)
150.82%
Revenue (1Y)-15.75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROICN/A
Net Margin-1251.10%
Op. Margin-662.58%
الأمان
Debt / Equity
N/A
Current Ratio0.92
Interest Coverage-8.01
التقييم
P/E Ratio
-3.35
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -15.75% | Revenue Growth (3Y) | 9.95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 150.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.72M | Net Income (TTM) | -184.21M |
| ROE | N/A | ROA | -154.84% |
| Gross Margin | 62.47% | Operating Margin | -662.58% |
| Net Margin | -1251.10% | Free Cash Flow (TTM) | -86.26M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.92 |
| Interest Coverage | -8.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.35 | P/B Ratio | N/A |
| P/S Ratio | 41.93 | PEG Ratio | -0.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 617.43M | Enterprise Value | 575.20M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 14.72M | 17.48M | 12.18M | 4.19M | 372,000.0 |
| Net Income | -184.21M | -110.43M | -54.27M | -49.64M | -31.62M |
| EPS (Diluted) | -3.08 | -2.43 | -1.31 | -1.27 | -0.93 |
| Gross Profit | 9.20M | 17.50M | 11.18M | 3.18M | -474,000.0 |
| Operating Income | -97.56M | -102.71M | -57.11M | -52.11M | -29.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 118.97M | 69.56M | 116.00M | 121.99M | 138.92M |
| Total Liabilities | 225.61M | 101.59M | 70.53M | 33.12M | 27.71M |
| Shareholders' Equity | -106.65M | -32.03M | 45.48M | 88.87M | 111.21M |
| Total Debt | 54.33M | 37.49M | 34.51M | 10.12M | 13.25M |
| Cash & Equivalents | 96.56M | 26.92M | 86.74M | 86.55M | 105.69M |
| Current Assets | 111.51M | 48.19M | 106.38M | 115.58M | 133.00M |
| Current Liabilities | 120.73M | 50.16M | 30.70M | 22.85M | 13.91M |